サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1656916

移植片準備システム：市場洞察・競合情勢・市場予測 (～2032年)

Graft Preparation System - Market Insights, Competitive Landscape, and Market Forecast - 2032

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
移植片準備システム：市場洞察・競合情勢・市場予測 (～2032年)
出版日: 2025年01月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

移植片準備システムの市場規模は、2024年の22億8,000万米ドルから、予測期間中はCAGR 4.17％で推移し、2032年には31億5,000万米ドルの規模に成長すると予測されています。

移植片準備システムに対するニーズの高まりは、いくつかの要因によって著しく高まっており、特に骨関連疾患や皮膚問題の有病率の増加が主な促進要因です。加えて、世界で実施される手術件数の増加、研究開発活動の活発化、主要企業間の提携も移植片準備システム市場の好循環に寄与する主な要因です。これらの要因が総合的に移植片準備システムの需要を促進し、予測期間中の良好な成長見通しを促進しています。

移植片準備システムの市場力学：

2023年の世界保健機関 (WHO) のデータによると、2019年には世界で推定5億2,800万人が変形性関節症と共存しています。移植片準備システムは、変形性関節症の治療のための骨関節移植片の調製に使用され、それによって市場の成長を促進しています。

世界保健機関 (WHO) が2023年に発表したデータによると、2019年には世界で約1,800万人が関節リウマチに罹患しています。このデータはまた、2019年に関節リウマチに罹患した人の70％が女性であり、55％が55歳以上であることを示しています。関節炎、骨粗鬆症、関節リウマチなどの骨関連疾患の有病率が上昇した結果、骨欠損や骨折の治癒を助ける組織移植片を調製する移植片準備システムの需要が高まると考えられています。

タイプ別では、骨移植の部門が2024年に大きな収益シェアを示すと推定されます。これは、骨機能回復のために移植システムを必要とする骨関連疾患の有病率が上昇していることに起因しています。主に靭帯再建術や人工膝関節置換術で利用される軟組織や骨の移植片は、移植片作製デバイスによって採取・作製され、手術部位に移植できる状態にすることができます。市場の主要企業は、安全なACL手術を行うための高度な技術を開発しています。

地域別では、北米が2024年に最大の市場シェアを占めると予想されています。これは、スポーツ関連の怪我が増加していることに起因しています。さらに、同地域における老齢人口の増加も、北米の移植片準備システム市場の成長を促進する主な要因となっています。

当レポートでは、世界の移植片準備システムの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 移植片準備システム市場レポート：イントロダクション

  • 調査範囲
  • 市場セグメンテーション
  • 市場の前提因子

第2章 移植片準備システム市場：エグゼクティブサマリー

  • 市場概要

第3章 競合情勢

第4章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第5章 移植片準備システム市場：主要要因分析

  • 市場促進要因
    • 骨関連疾患や皮膚疾患の増加
    • 世界で行われる手術件数の増加
    • 主要企業間のR&D活動とパートナーシップの拡大
  • 市場抑制要因と課題
    • 開発と保守にかかる初期投資額の高さ
    • 規制上のハードルとコンプライアンスの問題
  • 市場機会
    • 移植準備デバイスへのAIの統合

第6章 移植片準備システム市場：ポーターのファイブフォース分析

第7章 移植片準備システム市場の評価

  • タイプ別
    • 皮膚移植システム
    • 軟部組織移植システム
    • 骨移植システム
  • 用途別
    • ACL再建術
    • PCL再建
    • 半月板修復・再建
    • 軟部組織修復
    • その他
  • エンドユーザー別
    • 病院・診療所
    • 学術研究機関
    • エステティックセンター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 移植片準備システム市場：企業・製品プロファイル

  • CONMED Corporation
  • Integra LifeSciences
  • Arthrex, Inc.
  • Stryker
  • Endologix LLC
  • Zimmer Biomet
  • Medtronic
  • Smith+Nephew
  • NOUVAG AG
  • Abbvie Inc.
  • CosmoBiomediCare
  • Terumo Corporation
  • Surtex Instruments Limited
  • Artivion, Inc.
  • De Soutter Medical
  • GR Bioure Surgical System Private Limited
  • LifeNet Health
  • BioTek
  • Johnson & Johnson Services, Inc.
  • AVITA Medical, Inc.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項・問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Graft Preparation System Market in Global (2022-2032)
  • Table 3: Graft Preparation System Market in Global by Type (2022-2032)
  • Table 4: Graft Preparation System Market in Global by Application (2022-2032)
  • Table 5: Graft Preparation System Market in Global by End-User (2022-2032)
  • Table 6: Graft Preparation System Market in Global by Geography (2022-2032)
  • Table 7: Graft Preparation System Market in North America (2022-2032)
  • Table 8: Graft Preparation System Market in the US (2022-2032)
  • Table 9: Graft Preparation System Market in Canada (2022-2032)
  • Table 10: Graft Preparation System Market in Mexico (2022-2032)
  • Table 11: Graft Preparation System Market in Europe (2022-2032)
  • Table 12: Graft Preparation System Market in France (2022-2032)
  • Table 13: Graft Preparation System Market in Germany (2022-2032)
  • Table 14: Graft Preparation System Market in the United Kingdom (2022-2032)
  • Table 15: Graft Preparation System Market in Italy (2022-2032)
  • Table 16: Graft Preparation System Market in Spain (2022-2032)
  • Table 17: Graft Preparation System Market in Rest of Europe (2022-2032)
  • Table 18: Graft Preparation System Market in Asia-Pacific (2022-2032)
  • Table 19: Graft Preparation System Market in China (2022-2032)
  • Table 20: Graft Preparation System Market in Japan (2022-2032)
  • Table 21: Graft Preparation System Market in India (2022-2032)
  • Table 22: Graft Preparation System Market in Australia (2022-2032)
  • Table 23: Graft Preparation System Market in South Korea (2022-2032)
  • Table 24: Graft Preparation System Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Graft Preparation System Market in Rest of the World (2022-2032)
  • Table 26: Graft Preparation System Market in the Middle East (2022-2032)
  • Table 27: Graft Preparation System Market in Africa (2022-2032)
  • Table 28: Graft Preparation System Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Graft Preparation System Market in Global (2022-2032)
  • Figure 3: Graft Preparation System Market in Global by Type (2022-2032)
  • Figure 4: Graft Preparation System Market in Global by Application (2022-2032)
  • Figure 5: Graft Preparation System Market in Global by End-User (2022-2032)
  • Figure 6: Graft Preparation System Market in Global by Geography (2022-2032)
  • Figure 7: Graft Preparation System Market in North America (2022-2032)
  • Figure 8: Graft Preparation System Market in the US (2022-2032)
  • Figure 9: Graft Preparation System Market in Canada (2022-2032)
  • Figure 10: Graft Preparation System Market in Mexico (2022-2032)
  • Figure 11: Graft Preparation System Market in Europe (2022-2032)
  • Figure 12: Graft Preparation System Market in France (2022-2032)
  • Figure 13: Graft Preparation System Market in Germany (2022-2032)
  • Figure 14: Graft Preparation System Market in the United Kingdom (2022-2032)
  • Figure 15: Graft Preparation System Market in Italy (2022-2032)
  • Figure 16: Graft Preparation System Market in Spain (2022-2032)
  • Figure 17: Graft Preparation System Market in Rest of Europe (2022-2032)
  • Figure 18: Graft Preparation System Market in Asia-Pacific (2022-2032)
  • Figure 19: Graft Preparation System Market in China (2022-2032)
  • Figure 20: Graft Preparation System Market in Japan (2022-2032)
  • Figure 21: Graft Preparation System Market in India (2022-2032)
  • Figure 22: Graft Preparation System Market in Australia (2022-2032)
  • Figure 23: Graft Preparation System Market in South Korea (2022-2032)
  • Figure 24: Graft Preparation System Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Graft Preparation System Market in Rest of the World (2022-2032)
  • Figure 26: Graft Preparation System Market in the Middle East (2022-2032)
  • Figure 27: Graft Preparation System Market in Africa (2022-2032)
  • Figure 28: Graft Preparation System Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0855

Graft Preparation System Market by Type (Skin Grafting System, Soft Tissue Grafting System, and Bone Grafting System), Application (ACL Reconstruction, PCL Reconstruction, Meniscus Repair and Reconstruction, Soft Tissue Repair, and Others), End-User (Hospitals & Clinics, Academic and Research Institutes, Aesthetic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR Forecast till 2032 owing to the growing prevalence of bone-related disorders and rise in number of surgeries performed in the world

The graft preparation system market was valued at USD 2.28 billion in 2024, growing at a CAGR of 4.17% during the forecast period from 2025 to 2032 to reach USD 3.15 billion by 2032. The growing need for graft preparation systems is witnessing significant growth, driven by several factors. The increasing prevalence of bone-related disorders and skin problems is a primary driver. Additionally, rise in the number of surgeries performed in the world and the growing R&D activities, partnerships among key players are key contributors to the positive trajectory of the graft preparation system market. These factors collectively propel the demand for graft preparation systems, fostering a favorable growth outlook during the forecast period from 2025 to 2032.

Graft Preparation System Market Dynamics:

According to data from the World Health Organization (WHO) in 2023, an estimated 528 million individuals were living with osteoarthritis in 2019 across the globe. A graft preparation system is used in the preparation of osteoarticular allograft for the treatment of osteoarthritis, thereby driving the market growth.

The data published by World Health Organization (WHO) in 2023, indicate that about 18 million individuals suffered from rheumatoid arthritis in 2019 around the world. The data also revealed that 70% of those affected by rheumatoid arthritis in 2019 were women, with 55% being over the age of 55. As a result of the increasing prevalence of bone-related disorders like arthritis, osteoporosis, and rheumatoid arthritis, there will be a growing demand for graft preparation systems to prepare tissue grafts that aid in the healing of bone defects and fractures. This trend is expected to contribute to the positive growth of the graft preparation system market.

The graft preparation system is utilized in plastic surgery to prepare skin grafts for covering damaged skin using tissue sourced from other areas of the body. Similarly, bone grafting involves surgically transplanting bone material to repair and reconstruct bones affected by disease or injury, offering a viable solution for bone restoration across various anatomical sites. Graft preparation devices and instruments are extensively employed for the preparation of soft tissue to address damaged skin, wound care, and bone restoration needs.

Key players in the market are concentrating their efforts on developing and commercialization of novel graft systems to increase graft harvesting to reduce morbidity during minimally invasive surgery. For instance, in August 2022, Orthofix Medical Inc., a US-based medical device company announced its strategic research partnership with CGBio which is a synthetic bone graft development company. Under this partnership, both companies collaborate on the clinical advancement and marketing of Novosis, a recombinant human bone morphogenetic protein-2 (rhBMP-2) bone growth material, along with potential future tissue regenerative solutions, targeting the markets of the United States and Canada.

However, the high initial investment in development and maintenance costs, and the regulatory hurdles and compliance issues, among others are some of the key constraints that may limit the growth of the graft preparation system market.

Graft Preparation System Market Segment Analysis:

Graft Preparation System Market by Type (Skin Grafting System, Soft Tissue Grafting System, and Bone Grafting System), Application (ACL Reconstruction, PCL Reconstruction, Meniscus Repair and Reconstruction, Soft Tissue Repair, and Others), End-User (Hospitals & Clinics, Academic and Research Institutes, Aesthetic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment, the bone grafting system category is estimated to amass a significant revenue share in the graft preparation system market in 2024. This is attributed to the rising prevalence of bone-related disorders that require a grafting system for the restoration of bone function. Soft tissue and bone grafts mainly utilized in ligament reconstruction and knee replacement can be harvested and prepared by grafting devices to make graft ready to implant at the site of surgery. Major players in the market are developing advanced procedures to perform secure ACL procedures. For instance, in March 2023, Smith+Nephew, a UK-based medical technology company, launched the UltraTRAC QUAD ACL Reconstruction Technique, a comprehensive solution comprising the innovative QUADTRAC Quadriceps Tendon Harvest Guide System, the X-WING Graft Preparation System, and a range of ULTRABUTTON Adjustable Fixation Devices. The QUADTRAC System represents a groundbreaking advancement as the premier integrated guide system for minimally invasive quadriceps graft harvesting. This innovative system offers direct visualization of the tendon while facilitating a controlled and consistent technique for harvesting.

Within the graft system, hamstring tendon grafts emerge as a prevalent choice for ACL reconstruction procedures. Typically harvested from the ipsilateral leg, the semitendinosus tendon, often combined with the gracilis tendon, serves as the primary source. These grafts are typically configured into quadruple-stranded constructs and are recognized for their similarity to the native ACL in terms of performance and biomechanical properties. According to Smith+Nephew in 2023, estimations indicate that the volume of ACL procedures in was exceed 350,000 cases in 2023 in the United States, with a forecasted continued growth rate of 5.7% compounded annually.

Therefore, the rising use of bone grafts which require a bone graft preparation system, and the development of advanced procedures by key players contribute to the growth of the segment, thereby driving the growth of the graft preparation system market during the forecast period.

North America is expected to dominate the Overall Graft Preparation System Market:

North America is expected to account for the largest market share in the graft preparation system market in 2024. This can be attributed to the rising number of sports-related injuries. Additionally, the growing geriatric population in the region is the key factor driving the growth of the graft preparation system market in North America.

According to a study published by the American Academy of Orthopedic Surgeons in 2023, titled "Epidemiology of sports injuries among high school athletes in the United States," uncovered that between 2015 and 2019, there were 15,531 injuries documented from 6,778,209 athletic exposures (AE). This translated to an overall injury rate of 2.29 injuries per 1,000 athletic exposures in the United States. This notable increase in sports-related injuries creates an increasing demand for tissue grafts in the United States, thereby contributing to the growth of the graft preparation system market in North America.

Data published by the Population Reference Bureau in January 2024, reported that the number of Americans aged 65 and above is projected to grow significantly, from 58 million in 2022 to 82 million by 2050, a 47% increase. Older people are more prone to tissue damage due to age-related tissue degeneration that can be cured by tissue allografts, which consequently propel the growth of the graft preparation system.

Therefore, the increasing sports-related injuries and the rising geriatric population are key factors driving the growth of the graft preparation system market in North America.

Graft Preparation System Market Key Players:

Some of the key market players operating in the graft preparation system market include CONMED Corporation, Integra LifeSciences, Arthrex, Inc., Stryker, Endologix LLC, Zimmer Biomet, Medtronic, Smith+Nephew, NOUVAG AG, Abbvie Inc., CosmoBiomediCare, Terumo Corporation, Surtex Instruments Limited, Artivion, Inc., De Soutter Medical, GR Bioure Surgical System Private Limited, LifeNet Health, BioTek, Johnson & Johnson Services, Inc., AVITA Medical, Inc., and others.

Recent Developmental Activities in the Graft Preparation System Market:

  • In June 2023, AVITA Medical, Inc., a US-based regenerative medicine company announced that the U.S. Food and Drug Administration (FDA) granted premarket approval (PMA), allowing the utilization of its RECELL(R) System for the treatment of full-thickness skin defects. The system is a device for harvesting autologous cells, which prepares, produces, and administers a regenerative cell suspension known as Spray-On Skin(TM) Cells, utilizing a small quantity of the patient's skin.
  • In March 2023, LifeNet Health, a US-based regenerative medicine company launched ViviGen MIS, a graft delivery system used in trauma procedures. ViviGen MIS comprises a pre-filled cannula and a sterile delivery device. This apparatus facilitates the efficient, reliable, and precise administration of ViviGen, a viable bone allograft, while ensuring exceptional clinical outcomes are maintained.

Key Takeaways from the Graft Preparation System Market Report Study

  • Market size analysis for current Graft Preparation System Market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Graft Preparation System market.
  • Various opportunities available for the other competitors in the Graft Preparation System Market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current Graft Preparation System market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Graft Preparation System market growth in the coming future?

Target Audience who can be benefited from this Graft Preparation System Market Report Study

  • Graft Preparation System product providers
  • Research organizations and consulting companies
  • Graft Preparation System related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Graft Preparation System
  • Various end-users who want to know more about the Graft Preparation System Market and the latest technological developments in the Graft Preparation System Market.

Frequently asked questions for the Graft Preparation System Market:

1. What are Graft Preparation System?

  • A Graft Preparation System is a specialized set of tools and equipment used in medical procedures to prepare tissue grafts for transplantation. These systems streamline the process by facilitating the harvesting, processing, and shaping of graft materials to ensure optimal compatibility and integration with the recipient site. They are essential in surgeries such as orthopedic procedures, plastic surgery, and cardiovascular surgeries, where tissue grafts are commonly used to repair or replace damaged tissues.

2. What is the market for the Graft Preparation System?

  • The graft preparation system market was valued at USD 2.28 billion in 2024, growing at a CAGR of 4.17% during the forecast period from 2025 to 2032 to reach USD 3.15 billion by 2032.

3. What are the drivers for the global Graft Preparation System market?

  • The graft preparation system market is expected to witness growth owing to factors such as the increasing prevalence of bone-related disorders and skin problems. Additionally, the rise in the number of surgeries performed in the world and the growing R&D activities and partnerships among key players are key contributors to the positive trajectory of the graft preparation system market. These factors collectively propel the demand for graft preparation systems, fostering a favorable growth outlook during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global Graft Preparation System market?

  • Some of the key market players operating in the graft preparation system include CONMED Corporation, Integra LifeSciences, Arthrex, Inc., Stryker, Endologix LLC, Zimmer Biomet, Medtronic, Smith+Nephew, NOUVAG AG, Abbvie Inc., CosmoBiomediCare, Terumo Corporation, Surtex Instruments Limited, Artivion, Inc., De Soutter Medical, GR Bioure Surgical System Private Limited, LifeNet Health, BioTek, Johnson & Johnson Services, Inc., AVITA Medical, Inc., and others.

5. Which region has the highest share in the global Graft Preparation System market?

  • North America is expected to account for the largest market share in the graft preparation system market in 2024. This can be attributed to the rising number of sports-related injuries. Additionally, the growing geriatric population in the region is the key factor driving the growth of the graft preparation system market in North America.

Table of Contents

1. Graft Preparation System Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Graft Preparation System Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Graft Preparation System Market Key Factors Analysis

  • 5.1. Graft Preparation System Market Drivers
    • 5.1.1. The increasing prevalence of bone-related disorders and skin problems
    • 5.1.2. The rise in the number of surgeries performed in the world
    • 5.1.3. The growing R&D activities and partnerships among key players
  • 5.2. Graft Preparation System Market Restraints and Challenges
    • 5.2.1. High initial investment in development and maintenance costs
    • 5.2.2. Regulatory hurdles and compliance issues
  • 5.3. Graft Preparation System Market Opportunity
    • 5.3.1. Integration of AI in graft preparation devices

6. Graft Preparation System Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Graft Preparation System Market Assessment

  • 7.1. By Type
    • 7.1.1. Skin Grafting System
    • 7.1.2. Soft Tissue Grafting System
    • 7.1.3. Bone Grafting System
  • 7.2. By Application
    • 7.2.1. ACL Reconstruction
    • 7.2.2. PCL Reconstruction
    • 7.2.3. Meniscus Repair and Reconstruction
    • 7.2.4. Soft Tissue Repair
    • 7.2.5. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals and Clinics
    • 7.3.2. Academic and research institutes
    • 7.3.3. Aesthetic Centers
    • 7.3.4. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Graft Preparation System Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.2.5. Spain Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Graft Preparation System Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.3.3. India Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Graft Preparation System Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.4.2. Africa Graft Preparation System Market Size in USD million (2022-2032)
      • 7.4.4.3. South America Graft Preparation System Market Size In USD Million (2022-2032)

8. Graft Preparation System Market Company and Product Profiles

  • 8.1. CONMED Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Integra LifeSciences
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Arthrex, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Stryker
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Endologix LLC
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Zimmer Biomet
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Medtronic
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Smith+Nephew
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. NOUVAG AG
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Abbvie Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. CosmoBiomediCare
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Terumo Corporation
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Surtex Instruments Limited
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Artivion, Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. De Soutter Medical
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. GR Bioure Surgical System Private Limited
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. LifeNet Health
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. BioTek
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Johnson & Johnson Services, Inc.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. AVITA Medical, Inc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us